News – Page 1113 – Endpoints News

Two R&D pros map a PhIII game plan with $65M round and a castoff from Pfizer

8 years ago

Novartis is sending 500 jobs to the scrap heap while adding 350 ‘high-tech’ positions for growth

8 years ago

Israel's Teva puts foreigner in line for CEO's job; Vertex wins expanded label for Kalydeco

8 years ago

#ASCO17 highlights: Roche ushers early-stage bispecific into view; Agios, Celgene unveil more AG-221 data; Plenty ...

8 years ago

Vesalius bags €65M biotech fund while Novartis vet Guidi canvases for a €50M gamble on Italian scientists

8 years ago

Upsized offering delivers $100M payoff to argenx as another biotech joins the IPO parade

8 years ago

Shire’s multibillion-dollar gamble on lanadelumab pays off with stellar PhIII data, quick marketing application

8 years ago

#ASCO17: Epizyme will hunt a quick OK for tazemetostat, despite disappointing analysts with new data

8 years ago

After a bruising turn as Sarepta CEO, Chris Garabedian is back in biotech with a new role as godfather to a bunch of ...

8 years ago

#ASCO17: Incyte gets a boost from a series of positive data snapshots for its epacadostat/Keytruda combo

8 years ago

GlycoMimetics stock rockets up on the latest ‘breakthrough’ title in cancer R&D

8 years ago

Syndax shares soar as lead drug clears a mid-stage cancer drug study hurdle

8 years ago

AbbVie loses a round in the heavyweight biosimilar fight over Humira patents

8 years ago

Decibel chief Holtzman champions Fenway as the new ‘hood in biotech; Aduro adds 2nd Keytruda combo for cancer

8 years ago

Novartis steps in to help seed a Michigan spinout’s move into the clinic with new eye drug

8 years ago

G1 Therapeutics joins a growing biotech winners circle with $105M IPO

8 years ago

FDA forces Concert Pharma to hit the brakes on a mid-stage study so it can review tox studies

8 years ago

J&J pitches its top 11 drugs in the pipeline — with a peak sales promise of $1B-plus

8 years ago

FDA shoves Bayer’s lymphoma drug copanlisib into the spotlight with its promise of a speedy review

8 years ago

Overwrought marketing? Ads, not research, create some pharma best-sellers

8 years ago

X-Chem forges another discovery deal, this time with Vertex

8 years ago

OrbiMed, J&J back $24M A round for microbiome startup; Sangamo, Pfizer win FDA fast track

8 years ago

AstraZeneca throws a monkey wrench in new GSK CEO’s first hiring decision, suing Luke Miels

8 years ago

With a $42M raise and a reverse merger, Synlogic makes a quick flip onto Nasdaq

8 years ago

First page Previous page 1110 1111 111211131114 1115 1116 Next page Last page